Press Releases Year: - Any -201920182017201620152014 Items per page 102550 Date Title and Summary Additional Formats Toggle SummaryJan 25, 2019 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Toggle SummaryJan 17, 2019 Alder BioPharmaceuticals® Appoints Paul Streck, M.D. Chief Medical Officer View HTML Toggle SummaryDec 31, 2018 Alder BioPharmaceuticals® to Present at the 37th Annual J.P. Morgan Healthcare Conference View HTML Toggle SummaryDec 14, 2018 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Toggle SummaryDec 11, 2018 Alder BioPharmaceuticals® Appoints Carlos Campoy Chief Financial Officer View HTML Toggle SummaryNov 08, 2018 Alder BioPharmaceuticals® to Present at Two Upcoming November Investor Conferences View HTML Toggle SummaryNov 05, 2018 Alder BioPharmaceuticals® Reports Third Quarter 2018 Financial and Operating Results View HTML Toggle SummaryOct 29, 2018 Alder BioPharmaceuticals® to Host Conference Call to Discuss Third Quarter 2018 Financial and Operating Results View HTML Toggle SummaryOct 23, 2018 Alder BioPharmaceuticals® Announces Positive Results From Pharmacokinetic Comparability Study for Eptinezumab View HTML Toggle SummaryOct 05, 2018 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
